β-Cell Dysfunction and Death

Advances in Molecular and Cell Biology

Volumn 29, Issue C, 1999, Pages 47-73

  Eizirik, DéScio L ^a   Hoorens, Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002614901     PISSN: 15692558     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2558(08)60088-0     Document Type: Article

References (140)

1. Adams J.M., and Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 281 (1998) 1322-1326
2. Allison J., Georgiou H.M., Strasser A., and Vaux D.L. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94 (1997) 3943-3947
3. Allison J., and Strasser A. Mechanisms of β-cell death in diabetes: A minor role for CD95. Proc. Natl. Acad. Sci. USA 95 (1998) 13818-13822
4. Augstein P., Stephens L.A., Allison J., Elefanty A.G., Ekberg M., Kay T.W.H., and Harrison L.C. Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol. Med. 4 (1998) 495-501
5. Bach J.F. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J. Autoimmun. 8 (1995) 439-463
6. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271 (1996) C1424-C1437
7. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., and Duke R.C. A role of CD95 ligand in preventing graft rejection. Nature 377 (1995) 630-632
8. Bellmann K., Jaattela M., Wissing D., Burkart V., and Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 391 (1996) 185-188
9. Bellmann K., Wenz A., Radons J., Burkart V., Kleemann R., and Kolb H. Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J. Clin. Invest. 95 (1995) 2840-2845
10. Bicknell G.R., and Cohen G.M. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem. Biophys. Res. Comm. 207 (1995) 40-47
11. Blume N., Skouv J., Larsson L.-I., Hoist J.J., and Madsen O.D. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J. Clin. Invest. 96 (1995) 2227-2235
12. Buja L.M., Eigenbrodt M.L., and Eigenbrodt E.H. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117 (1993) 1208-1214
13. Casciola-Rosen L.A., Anhalt G., and Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179 (1994) 1317-1330
14. Cetkovic-Cvrlje M., and Eizirik D.L. TNF-a and IFN-y potentiate the deleterious effects of IL- 1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6 (1994) 399-406
15. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway Jr. C.A., and Matis L.A. The role of Fas in autoimmune diabetes. Cell 89 (1997) 17-24
16. Cohen G.M., Sun X.-M., Snowden R.T., Dinsdale D., and Skilleter D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286 (1992) 331-334
17. Corbett J.A., Sweetland M.A., Wang J.L., Lancaster, Jr J.R., and McDaniel M.L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90 (1993) 1731-1735
18. Cummings M.C., Winterford C.M., and Walker N.I. Apoptosis. Am. J. Surg. Pathol. 21 (1997) 88-101
19. Cunningham J.M., Mabley J.G., and Green I.C. Interleukin-1 P-mediated inhibition of arginase in RINm5F cells. Cytokine 9 (1997) 570-576
20. Darville M.I., and Eizirik D.L. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41 (1998) 1101-1108
21. 6-methylguanine in human cell killing, sister chromatid exchange induction and mutagenesis: A review. J. Cell. Sci. 6 Suppl. (1987) 333-353
22. Delaney C.A., Green M.H., Lowe J.E., and Green I.C. Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett. 333 (1993) 291-295
23. Delaney C.A., Pavlovic D., Hoorens A., Pipeleers D.G., and Eizirik D.L. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138 (1997) 2610-2614
24. Delaney C.A., Tyrberg B., Bouwens L., Vaghef H., Hellman B., and Eizirik D.L. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett. 394 (1996) 300-306
25. De Vos A., Heimberg H., Quartier E., Huypens P., Bouwens L., Pipeleers D., and Schuit F. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Invest. 96 (1995) 2489-2495
26. Di Matteo M.A., Loweth A.C., Thomas S., Mabley J.G., Morgan N.G., Thorpe J.R., and Green I.C. Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin secreting cell lines, but dictate cell death by different mechanisms. Apoptosis 2 (1997) 164-177
27. Dypbukt J.M., Ankarcrona M., Burkitt M., Sjöholm A., Ström K., Orrenius S., and Nicotera P. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J. Biol. Chem. 269 (1994) 30553-30560
28. Eizirik D.L. Interleukin-1 ß induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 10 (1991) 107-114
29. Eizirik D.L. Beta-cell defence and repair mechanisms in human pancreatic islets. Horm. Metab. Res. 28 (1996) 302-305
30. Eizirik D.L., Delaney C.A., Green M.H., Cunningham J.M., Thorpe J.R., Pipeleers D.G., Hellerström C., and Green I.C. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol. 118 (1996) 71-83
31. Eizirik D.L., Flodström M., Karlsen A.E., and Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta-cells. Diabetologia 39 (1996) 875-890
32. Eizirik D.L., Jansson L., Flodström M., Hellerström C., and Andersson A. Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice. J. Clin. Endocrinol. Metab. 82 (1997) 2660-2663
33. Eizirik D.L., Korbutt G.S., and Hellerström C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J. Clin. Invest. 90 (1992) 1263-1268
34. Eizirik D.L., and Migliorini R.H. Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein carbohydrate-free diet. Diabetes 33 (1984) 383-388
35. Eizirik D.L., and Pavlovic D. Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM? Diabetes Metab. Rev. 13 (1997) 293-307
36. Eizirik D.L., Pipeleers D.G., Ling Z., Welsh N., Hellerstrom C., and Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc. Natl. Acad. Sci. USA 91 (1994) 9253-9256
37. Eizirik D.L., Sandler S., Ahnström G., and Welsh M. Exposure of pancreatic islets to different alkylating agents decreases mitochondrial DNA content but only streptozotocin induces long-lasting functional impairment of β-cells. Biochem. Pharmacol. 42 (1991) 2275-2282
38. Eizirik D.L., Sandler S., Hallberg A., Bendtzen K., Sener A., and Malaisse W.J. Differential sensitivity to β-cell secretagogues in rat pancreatic islets exposed to human interleukin-1β. Endocrinology 125 (1989) 752-759
39. Eizirik D.L., Sandler S., and Palmer J.P. Repair of pancreatic b-cells. A relevant phenomenon in early IDDM?. Diabetes 42 (1993) 1383-1391
40. Eizirik D.L., Sandler S., Welsh N., Cetkovic-Cvrlje M., Nieman A., Geller D.A., Pipeleers D.G., Bendtzen K., and Hellerström C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93 (1994) 1968-1974
41. Eizirik D.L., Spencer P., and Kisby G.E. Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem. Pharmacol. 51 (1996) 1585-1591
42. Eizirik D.L., Welsh N., and Hellerström C. Predominance of stimulatory effects of interleukin- 1β on isolated human pancreatic islets. J. Clin. Endocrinol. Metab. 76 (1993) 399-403
43. Eizirik D.L., Welsh M., Strandell E., Welsh N., and Sandler S. Interleukin-1 b depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127 (1990) 2290-2297
44. Flodström M., Chen M.-C., Smismans A., Pipeleers D.G., Schuit F., and Eizirik D.L. Interleukin-1β increases arginine accumulation and activates the citrulline-nitric oxide cycle in rat pancreatic β-cells. Cytokine (1999) (in press).
45. Flodström M., and Eizirik D.L. Interferon-γ-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide formation. Endocrinology 138 (1997) 2747-2753
46. Flodström M., Niemann A., Bedoya F.J., Morris Jr. S.M., and Eizirik D.L. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic β-cells: Induction of argininosuccinate synthetase by cytokines. Endocrinology 136 (1995) 3200-3206
47. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell. Biol. 119 (1992) 493-501
48. Gerbitz K.-D., Gempel K., and Brdiczka D. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 45 (1996) 113-126
49. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., and Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71 (1994) 219-225
50. Grankvist K., Marklund S.L., and Taljedal L.B. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199 (1981) 393-398
51. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., and Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21 (1995) 1465-1468
52. Griffith O.W., and Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57 (1995) 707-736
53. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
54. Heller B., Wang Z.Q., Wagner E.F., Radons J., Burkle A., Fehsel K., Burkart V., and Kolb H. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270 (1995) 11176-11180
55. Hirasawa K., Jun H.S., Maeda K., Kawaguchi Y., Itagaki S., Mikami T., Baek H.S., Doi K., and Yoon J.W. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virology 71 (1997) 4024-4031
56. Hohmeier H.-E., Thigpen A., Tran V.V., Davis R., and Newgard C.B. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest. 101 (1998) 1811-1820
57. Hoorens A., Van de Casteele M., Klöppel G., and Pipeleers D. Glucose promotes survival of rat pancreatic β cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J. Clin. Invest. 98 (1996) 1568-1574
58. Hyans J. Look Ma, no chromosomes!. Nature 382 (1996) 397-398
59. Ilkova H., Glaser B., Tunckale A., Bagriaçik N., and Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20 (1997) 1353-1356
60. Itoh N., Imagawa A., Hanafusa T., Waguri M., Yamamoto K., Iwahashi H., Moriwaki M., Nakajima H., Miyagawa J., Namba M., Makino S., Nagata S., Kono N., and Matsuzawa Y. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186 (1997) 613-618
61. Iwahashi H., Hanafusa T., Eguchi Y., Nakajima H., Miyagawa J., Itoh N., Tomita K., Namba M., Kuwajima M., Noguchi T., Tsujimoto Y., and Matsuzawa Y. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: Inhibition by Bcl-2. Diabetologia 39 (1996) 530-536
62. Jansson L., Eizirik D.L., Pipeleers D.G., Borg L.A.H., Hellerström C., and Andersson A. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J. Clin. Invest. 96 (1995) 721-726
63. Jiang Z., and Woda B.A. Cytokine gene expression in the islets of the diabetic Biobreeding/ Worcester rat. J. Immunol. 146 (1991) 2990-2994
64. 2+ channels exposed to serum from patients with type I diabetes. Science 261 (1993) 86-90
65. Karlsen A., Pavlovic D., Nielsen K., Jensen J., Andersen H.U., Pociot E., Mandrup-Poulsen T., Eizirik D.L., and Nerup J. Cytokine induced nitric oxide and interleukin-1 converting enzyme may represent different pathways of cytokine induced β-cell destruction. Diabetologia 41 Suppl. 1 (1998) A56
66. Keymelen B., Ling Z., Gorus F.K., Delvaux G., Bouwens L., Grupping A., Hendrieckx C., Pipeleers-Marichal M., Van Schravendijk C., Salmela K., and Pipeleers D.G. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41 (1998) 452-459
67. Kiekens R., In't Veld P., Mahler T., Schuit E., Van De Winkel M., and Pipeleers D. Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J. Clin. Invest. 89 (1992) 117-125
68. Kolb H., and Kröncke K.-D. IDDM-Lessons from the low-dose streptozotocin model in mice. Diabetes Rev. 1 (1993) 116-126
69. Korbutt G.S., Elliott J.F., and Rajotte R.V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46 (1997) 317-322
70. Korsgren O., Jansson L., Sandler S., and Andersson A. Hyperglycemia-induced B-cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J. Clin. Invest. 86 (1990) 2161-2168
71. Koyama M., Wada R., Sakuraba H., Mizukami H., and Yagihashi S. Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin dependent diabetes mellitus. Am. J. Pathol. 153 (1998) 537-545
72. Kröncke K.-D., Fehsel K., and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol. 113 (1998) 147-156
73. Kubish M.-H., Wang J., Bray T.M., and Philipps J.P. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress. Diabetes 46 (1997) 1563-1566
74. Kurrer M.O., Pakala S.V., Hanson H.L., and Katz J.D. β cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94 (1997) 213-218
75. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEBJ. 11 (1997) 118-124
76. Lau H.T., Yu M., Fontana A., and Stoeckert Jr. C.J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273 (1996) 109-112
77. Leahy J.L. Impaired β-cell function with chronic hyperglycemia: "Overworked β-cell" hypothesis. Diabetes Rev. 4 (1996) 298-319
78. Leahy J.L., Bonner-Weir S., and Weir G.C. β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15 (1992) 442-455
79. LeDoux S.P., Woodley S.E., Patton N.J., and Wilson G.L. Mechanisms of nitrosoureainduced B-cell damage. Alterations of DNA. Diabetes 35 (1986) 866-872
80. Leist M., Single B., Castoldi A.F., Kühlne S., and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med. 185 (1997) 1481-1486
81. Ling Z., Hannaert J.C., and Pipeleers D. Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 37 (1994) 15-21
82. Lorenzo A., Razzaboni B., Weir G.C., and Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368 (1994) 756-760
83. Loweth A.C., Williams G.T., James R.F.L., Scarpello J.H.B., and Morgan N.G. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to IL-1β and Fas ligation. Diabetes 47 (1998) 727-732
84. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
85. Majno G., and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146 (1995) 3-15
86. Malaisse W.J. The beta cell in non-insulin-dependent diabetes: giving light to the blind. Diabetologia 37 Suppl. 2 (1994) S36-S42
87. Malaisse W.J., Maggetto C., Leclerk-Meyer V., and Sener A. Interference of glycogenolysis with glycolysis in pancreatic islets from glucose-infused rats. J. Clin. Invest. 91 (1993) 432-436
88. Malaisse W.J., Malaisse-Lagae F., Sener A., and Pipeleers D.G. Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. U S A 79 (1982) 927-930
89. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39 (1996) 1005-1029
90. Margulis B.A., Sandler S., Eizirik D.L., Welsh N., and Welsh M. Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1β-induced impaired β-cell function. Diabetes 40 (1991) 1418-1422
91. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
92. Moncada S., Higgs A., and Furchgott R. International Union of Pharmacology nomenclature in nitric oxide research. Pharmacol. Rev. 49 (1997) 137-142
93. Morris Jr. S.M., and Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266 (1994) E829-E839
94. Mundle S.D., and Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab. Invest. 72 (1995) 611-613
95. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
96. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
97. 6"methylguanine in rat pancreatic β-cells after exposure to N-methyl-N-nitrosourea. Diabetes 42 (1993) 1187-1194
98. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139 (1991) 271-279
99. Niemann A., Björklund A., and Eizirik D.L. Studies on the molecular regulation of the inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Mol. Cell. Endocrinol. 106 (1994) 151-155
100. O'Brien B.A., Harmon B.V., Cameron D.P., and Allan D.J. Beta cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J. Pathol. 178 (1996) 176-181
101. O'Brien B.A., Harmon B.V., Cameron D.P., and Allan D.J. Apoptosis is the mode of P-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46 (1997) 750-757
102. Pavlovic D., Chen M.-C., Bouwens L., Eizirik D.L., and Pipeleers D. Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 48 (1999) 29-33
103. Peng H.B., Libby P., and Liao J.K. Induction and stabilization of IKB alpha by nitric oxide mediates inhibition of NF-KB. J. Biol. Chem. 270 (1995) 14214-14219
104. Pettepher C.C., LeDoux S.P., Bohr V.A., and Wilson G.L. Repair of alkali-labile sites within the mitochondrial DNA of RINr38 cells after exposure to the nitrosourea streptozotocin. J. Biol. Chem. 266 (1991) 3113-3117
105. Pipeleers D., and Van de Winkel M. Pancreatic B cell possess defense mechanisms against cell-specific toxicity. Proc. Natl. Acad. Sci. USA 83 (1986) 5267-5271
106. Polonsky K.S., Sturis J., and Bell G.I. Non-insulin dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334 (1996) 777-783
107. Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1 (1993) 215-240
108. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., and Bleackley R.C. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology 137 (1996) 2093-2099
109. Rabinovitch A., Suarez-Pinzon W.L., Strynadka K., Lakey J.R.T., and Rajotte R.V. Human pancreatic islet β-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J. Clin. Endocrinol. Metab. 81 (1996) 3197-3202
110. Radons J., Heller B., Burkle A., Hartmann B., Rodriguez M.L., Kroncke K.D., Burkart V., and Kolb H. Nitric oxide toxicity in islet cells involves poly (ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem. Biophys. Res. Commun. 199 (1994) 1270-1277
111. Rerup C.C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22 (1970) 485-518
112. Robertson R.P., Olson L.K., and Zhang H.-J. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43 (1994) 1085-1089
113. Saini K.S., Thompson C., Winterford C.M., Walker N.I., and Cameron D.P. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem. Mol. Biol. Internat. 39 (1996) 1229-1236
114. Sako Y., and Grill V.E. Coupling of β-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39 (1990) 1580-1583
115. Sánchez-Margalet V., Lucas M., Solano F., and Goberna R. Sensitivity of insulin-secreting RIN m5F cells to undergoing apoptosis by the protein kinase C inhibitor staurosporine. Exp. Cell Res. 209 (1993) 160-163
116. Sandler S., Eizirik D.L., Svensson C., Strandell E., Welsh M., and Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10 (1991) 241-253
117. Scaglia L., Cahill C.J., Finegood D.T., and Bonner-Weir S. Apoptosis participates in the remodelling of the endocrine pancreas in the neonatal rat. Endocrinology 138 (1997) 1736-1741
118. Scaglia L., Smith F.E., and Bonner-Weir S. Apoptosis contributes to the involution of the β cell mass in the post partum rat pancreas. Endocrinology 136 (1995) 5461-5468
119. Shah S., Malone J.I., and Simpson N.E. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N. Engl. J. Med. 320 (1989) 550-554
120. 2+ accumulation and early DNA fragmentation with cell death. Toxicol. Appl. Pharmacol. 111 (1991) 242-254
121. Shimabukuro M., Wang M.-Y., Zhou Y.-T., Newgard C.B., and Unger R.H. Protection against lipoapoptosis of β cells trough leptin dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA 95 (1998) 9558-9561
122. Stassi G., De Man R., Trucco G., Rudert W., Testi R., Galluzzo A., Giordano C., and Trucco M. Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186 (1997) 1193-1200
123. Steller H. Mechanisms and genes of cellular suicide. Science 267 (1995) 1445-1449
124. Strandell E., Eizirik D.L., and Sandler S. Reversal of β-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. J. Clin. Invest. 85 (1990) 1944-1950
125. Strandell E., Sandler S., Boitard C., and Eizirik D.L. Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice. Diabetologia 35 (1992) 924-931
126. Suarez-Pinzon W.L., Szabo C., and Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β-cells. Diabetes 46 (1997) 907-911
127. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
128. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 312-316
129. Tomei L.D., Shapiro J.P., and Cope F.O. Apoptosis in C3H/10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA 90 (1993) 853-857
130. Welch M.J. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72 (1992) 1063-1081
131. Welsh N., Eizirik D.L., Bendtzen K., and Sandler S. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129 (1991) 3167-3173
132. Welsh N., Margulis B., Bendtzen K., and Sandler S. Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide-but not interleukin-1β-induced inhibition of glucose metabolism in rat pancreatic islets. J. Endocrinol. 143 (1994) 151-156
133. Welsh N., Margulis B., Borg L.A., Wiklund H.J., Saldeen J., Flodström M., Mello M.A., Anders-son A., Pipeleers D.G., Hellerström C., and Eizirik D.L. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol. Med. 1 (1995) 806-820
134. Wijsman J.H., Jonker R.R., Keijzer R., Van De Velde C.J.H., Cornelisse C.J., and Van Dierendonck J.H. A new method to detect apoptosis in paraffin sections: In situ end-labelling of fragmented DNA. J. Histochem. Cytochem. 41 (1993) 7-12
135. Wilson G.L., Patton N., and LeDoux S.P. Mitochondrial DNA in β-cells is a sensitive target for damage by nitric oxide. Diabetes 46 (1997) 1291-1295
136. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endo-nuclease activation. Nature 284 (1980) 555-556
137. Xie Q., and Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 56 (1994) 576-582
138. Yamada K., Takane-Gyotoku N., Yuan X., Ichikawa R., Inada C., and Nonaka K. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39 (1996) 1306-1312
139. Zakeri Z.R., Quaglino D., Latham T., and Lockshin R.A. Delayed intemucleosomal DNA fragmentation in programmed cell death. FASEB J. 7 (1993) 470-478
140. Zhou Y.-P., and Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93 (1994) 870-876